Carious Teeth
Conditions
Brief summary
This study is aimed to evaluate the clinical performance of new One-shade universal composite resin as posterior restoration using US Public Health Service USPSH criteria for color match, marginal adaptation, surface texture, retention, recurrent caries and others after 1, 3, 6 and 9 months.
Detailed description
One operator will place all restorations under rubber-dam isolation. The patients will receive restorations with both materials, randomly after shade selection (The shade of single shade universal resin composite Omnichroma will be taken before and after placement into the cavity). During the referred period, only the two composites in study will be placed in posterior teeth in the dental office. The various materials' application procedure will be applied according to manufacturer's instructions.
Interventions
OTHERUS Public Health Service USPSH criteria for assessment of success of resin composite restorations
US Public Health Service USPSH criteria for color match, marginal adaptation, surface texture, retention, recurrent caries and others after 1, 3, 6 and 9 months.
Sponsors
Minia University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
25 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
* • They should have an acceptable oral hygiene level. * Presence of at least two occlusal carious lesions to be restored with two different types of composite. * The two studied materials restorations should be used in approximately the same sized lesions or within the same extension. * Age range between 25 and 45years.
Exclusion criteria
* • Severe or active periodontal or carious disease and heavy bruxism or a traumatic occlusion * Patients with a compromised medical history, or had received therapeutic irradiation to the head and neck region. * Alcoholic and smoker patients. * Patients had participated in a clinical trial within 6 months before commencement of this trial. * Patients unable to return for recall appointment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| USPSH criteria | For 9 months | Alpha and Beta are clinically successful, Charlie and Delta are clinically failure |
Countries
Egypt
Outcome results
None listed